Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIVA vs VIMA on GSK-3beta in On-pump CABG Patients
NCT02686710Phase 4Terminated
- Sponsor
- MONIKI
- Start
- Feb 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sevoflurane and propofol in coronary artery disease (CAD) (3 arms), sponsored by MONIKI. Primary endpoints: GSK-3beta base line content, GSK-3beta content after induction and 1 more. Started Feb 2016; status: terminated.
02
Drugs
sevofluranepropofol
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02686710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02686710.